150 related articles for article (PubMed ID: 17960865)
1. Antipsychotic polypharmacy at the University Psychiatric Hospital in Serbia.
Divac N; Jasović-Gasić M; Samardzić R; Lacković M; Prostran M
Pharmacoepidemiol Drug Saf; 2007 Nov; 16(11):1250-1. PubMed ID: 17960865
[TBL] [Abstract][Full Text] [Related]
2. Prevalence, utilization patterns, and predictors of antipsychotic polypharmacy: experience in a multistate Medicaid population, 1998-2003.
Morrato EH; Dodd S; Oderda G; Haxby DG; Allen R; Valuck RJ
Clin Ther; 2007 Jan; 29(1):183-95. PubMed ID: 17379060
[TBL] [Abstract][Full Text] [Related]
3. [Prescribing patterns of antipsychotics in 13 French psychiatric hospitals].
Bret P; Bret MC; Queuille E
Encephale; 2009 Apr; 35(2):129-38. PubMed ID: 19393381
[TBL] [Abstract][Full Text] [Related]
4. Antipsychotic medication coprescribing in a large state hospital system.
Jaffe AB; Levine J
Pharmacoepidemiol Drug Saf; 2003; 12(1):41-8. PubMed ID: 12616846
[TBL] [Abstract][Full Text] [Related]
5. Prevalence, incidence and persistence of antipsychotic drug prescribing in the Italian general population: retrospective database analysis, 1999-2002.
Mirandola M; Andretta M; Corbari L; Sorio A; Nosè M; Barbui C
Pharmacoepidemiol Drug Saf; 2006 Jun; 15(6):412-20. PubMed ID: 16287199
[TBL] [Abstract][Full Text] [Related]
6. Factors associated with antipsychotic dosing in psychiatric inpatients: a prospective study.
Barbui C; Biancosino B; Esposito E; Marmai L; Donà S; Grassi L
Int Clin Psychopharmacol; 2007 Jul; 22(4):221-5. PubMed ID: 17519645
[TBL] [Abstract][Full Text] [Related]
7. Psychotropic medication changes, polypharmacy, and the risk of early readmission in suicidal adolescent inpatients.
Fontanella CA; Bridge JA; Campo JV
Ann Pharmacother; 2009 Dec; 43(12):1939-47. PubMed ID: 19934394
[TBL] [Abstract][Full Text] [Related]
8. Patient characteristics and process factors associated with antipsychotic polypharmacy in a nationwide sample of psychiatric inpatients in Italy.
Santone G; Bellantuono C; Rucci P; Picardi A; Preti A; de Girolamo G
Pharmacoepidemiol Drug Saf; 2011 May; 20(5):441-9. PubMed ID: 21523847
[TBL] [Abstract][Full Text] [Related]
9. Clinical and social determinants of antipsychotic polypharmacy for Chinese patients with schizophrenia.
Xiang YT; Weng YZ; Leung CM; Tang WK; Ungvari GS
Pharmacopsychiatry; 2007 Mar; 40(2):47-52. PubMed ID: 17447172
[TBL] [Abstract][Full Text] [Related]
10. Are patients with schizophrenia under-treated with second-generation antipsychotics? A pilot study of the prescription practices of German psychiatrists.
Hamann J; Pfeiffer H; Leucht S; Kissling W
Pharmacopsychiatry; 2003 Nov; 36(6):309-12. PubMed ID: 14663656
[TBL] [Abstract][Full Text] [Related]
11. Antipsychotic polypharmacy in outpatients at Birch Hill Hospital: incidence and adherence to guidelines.
Ranceva N; Ashraf W; Odelola D
J Clin Pharmacol; 2010 Jun; 50(6):699-704. PubMed ID: 20056801
[TBL] [Abstract][Full Text] [Related]
12. Antipsychotic polypharmacy: a needle in a haystack?
López de Torre A; Lertxundi U; Hernández R; Medrano J
Gen Hosp Psychiatry; 2012; 34(4):423-32. PubMed ID: 22460003
[TBL] [Abstract][Full Text] [Related]
13. Prescription profiles for pharmacological treatment of Japanese inpatients with schizophrenia: comparison between 2007 and 2009.
Yoshio T; Inada T; Uno J; Miwa T; Kitagawa K; Miyahara Y; Umeda K; Kato T; Inagaki A; Nabeshima T
Hum Psychopharmacol; 2012 Jan; 27(1):70-5. PubMed ID: 22249957
[TBL] [Abstract][Full Text] [Related]
14. The prescribing pattern of a new antipsychotic: a descriptive study of aripiprazole for psychiatric in-patients.
Andersen SE; Johansson M; Manniche C
Basic Clin Pharmacol Toxicol; 2008 Jul; 103(1):75-81. PubMed ID: 18346047
[TBL] [Abstract][Full Text] [Related]
15. Potentially inappropriate prescribing to hospitalised patients.
Radosević N; Gantumur M; Vlahović-Palcevski V
Pharmacoepidemiol Drug Saf; 2008 Jul; 17(7):733-7. PubMed ID: 18050360
[TBL] [Abstract][Full Text] [Related]
16. Treatment pathway and patterns of clozapine prescribing for schizophrenia in New Zealand.
Wheeler AJ
Ann Pharmacother; 2008 Jun; 42(6):852-60. PubMed ID: 18477732
[TBL] [Abstract][Full Text] [Related]
17. Antipsychotic polypharmacy and high-dose prescription in schizophrenia: a 5-year comparison.
Roh D; Chang JG; Kim CH; Cho HS; An SK; Jung YC
Aust N Z J Psychiatry; 2014 Jan; 48(1):52-60. PubMed ID: 23671214
[TBL] [Abstract][Full Text] [Related]
18. Changes in utilisation of anticholinergic drugs after initiation of cholinesterase inhibitors.
Robinson M; Rowett D; Leverton A; Mabbott V
Pharmacoepidemiol Drug Saf; 2009 Aug; 18(8):659-64. PubMed ID: 19548222
[TBL] [Abstract][Full Text] [Related]
19. Trends in consumption of psychiatric drugs in Serbia and Montenegro 2000-2004.
Divac N; Tosevski DL; Babić D; Djurić D; Prostran M; Samardzić R
Pharmacoepidemiol Drug Saf; 2006 Nov; 15(11):835-8. PubMed ID: 16958148
[TBL] [Abstract][Full Text] [Related]
20. [Prescribing practice of psychotropic drugs in a psychiatric university clinic].
Ambühl B; Würmle O; Michel K
Psychiatr Prax; 1993 Mar; 20(2):70-3. PubMed ID: 8103601
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]